StonvexLoading…
StonvexStonvexStonvexCore line items from MCS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-26 | Annual 2023 2023-12-28 | Annual 2022 2022-12-29 |
|---|---|---|---|---|
Revenue | $758.46M | $735.56M | $729.58M | $677.39M |
Operating Income | $17.06M | $16.17M | $33.93M | $8.31M |
Net Income | $12.69M | $-7.79M | $14.79M | $-11.97M |
EPS (Diluted) | Not available | Not available | Not available | Not available |
Total Assets | $1.01B | $1.04B | $1.07B | $1.06B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $23.45M | $40.84M | $55.59M | $21.70M |
Free Cash Flow OCF − CapEx | $989.00K | $24.73M | $63.85M | $56.37M |
Shares Outstanding | 31.28M | 31.89M | 40.99M | 31.49M |